Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease
An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.
https://www.news-medical.net/n....ews/20241114/Phase-3
Discover the world at Altruu, The Discovery Engine